Try our Advanced Search for more refined results
Life Sciences - February, 2018
266 articles
- Del. Class Suit Over Weight Loss Drug Trial Leaks Tossed
- King & Spalding DQ'd In Boehringer Unit Arbitration
- Deals Rumor Mill: Bayer, Embraer, NIO
- Mallinckrodt Hit With Subpoena To Provide Opioid Info
- Nelson Mullins Opens Baltimore Office With 11 New Hires
- MedImmune Spins Drugs Into New Biotech Co., Raises $250M
- Cherokee Slam Bid To Take Opioid Suit To Federal Court
- Drug Cos. Want Blue Cross Unit Sanctioned In Aggrenox MDL
- Shkreli Argues For Short Prison Stint Ahead Of Sentencing
- Doc Admits Letting Aegerion See Patient Data, Target Teens
- King & Spalding Nabs Cooley's Ex-IP Litigation Head
- Ex-Merck Exec Settles With SEC Over Insider Trading Claims
- Zimmer Must Face Majority Of NJ Hip Implant Suit
- DOJ Unveils Opioid Task Force, Eyes Foray Into Ohio MDL
- Ex-Drug Distribution Exec Convicted In $50M Scheme
- Natus Medical Slips Investor Suit Over Venezuela Contract
- FTC Says Robocalls Misled Consumers As Cos. Return Fire
- CVS, Aetna Pitch Lawmakers On Merger Benefits
- Calif. Can't Require Monsanto To Add Weed Killer Warning
- Full Fed. Circ. Urged To Rethink Illumina Patent Challenge
- FDA Warning Wire: False Data, Cleanliness Issues Overseas
- Vitamin C Importers Urge Justices To Revive Antitrust Suit
- Why Machine Learning Should Matter To Lawyers
- Ky. Can't Reclaim Firm's $4.2M Cut Of OxyContin Settlement
- Navigating The Complexities Of A Digital Health Transaction
- Litigating The Internet Of Things
- Claim Scope And Apportionment At Fed. Circ.
- Jury Sides With Pfizer, Serono In Biogen's IP Spat
- In Surprising Move, PTAB Tackles Tribal Immunity Head-On
- Plaintiffs Agree To Release Pfizer From Testosterone MDL
- Judge Keeps Retaliation Suit Against Medical Co. Alive
- Allergan Urges 1st Circ. To Reverse Asacol Class Cert.
- GSK Hid Zofran Data From FDA, Families Say
- Shkreli Caused $10.4M In Losses, Not Zero, Judge Rules
- Judge Orders Redo In First AbbVie Testosterone MDL Trial
- Doctor Charged Over Sharing Patient Info With Aegerion
- Tribe Not Immune From Restasis IP Challenges, PTAB Says
- Health Hires: Goodwin, Alston & Bird, Lucas & Mercanti
- Meningitis Pharmacist Must Forfeit $175K Before Restitution
- Amgen Denied Full Fed. Circ. Hearing On Repatha Patents
- Amgen Fears 'Staggering Loss' After FDA Exclusivity Denial
- Judge Won't Disturb Jury Verdict On Health Supplement IP
- Fed. Circ. 'Divided' On Patent Eligibility, Justices Told
- No 'Rubber Stamp' For SEC Penalties In NJ Biotech Fraud Row
- Endo, Auxilium And GSK Reach Deal In Testosterone MDL
- Opioid MDL Attys Clash With DEA Over Drug Data
- Shkreli Can't Beat Stock Fraud Rap Post-Trial
- Valeant Says Stomach Ulcer Drug Is Being Imported Unfairly
- US Steps Into Tricare FCA Suit Against Pharmacy, PE Owner
- Man Will Die From J&J Talc-Caused Mesothelioma, Jury Told
- 4th Circ. Resurrects Medical Device Co. Investor Suit
- Endo Settles Rest Of Lidoderm Antitrust Suit
- Rituxan Patent Survives Celltrion, Pfizer PTAB Challenges
- 2 Biotechs Brave Volatility To Raise $401M In Follow-Ons
- 6th Circ. Won't Revive Spinal Patients' Bone Growth Suit
- Horizon Pharma Fired Aegerion's FCA Whistleblower: Suit
- 2 Tibet Pharma Defendants May Appeal Last Count In IPO Suit
- GSK Has Duty To Warn About Generics, Widow Tells 7th Circ.
- Dorsey Scores Team Of 10 IP Attys From Holland & Hart
- Calif. Justices Take Up Actavis' Opioid Suit Coverage Bid
- Insurance Tips For Defendants In Opioid Litigation
- The Continuing Evolution Of Personal Jurisdiction
- Ex-Herbalife Sellers Blast Arbitration Bid In $1B RICO Suit
- AIG Denied Quick Win In Becton Antitrust Coverage Fight
- DC Circuit Urged To Knock Down FDA E-Cig Rule
- CooperVision To Pay $3M To End Contact Price-Fixing Suit
- Express Scripts Beats NY Pharmacy's Antitrust, Contract Suit
- Xarelto User Says Pa. Judge Wrongly Axed $28M Award
- Surgical Robotics Co. Reaps $118M In Private Financing
- Feds Can't Get Israeli Court Info In $163M Perrigo Tax Row
- From NJ To Texas: How The Courts Fared At The Fed. Circ.
- Purdue Pharma Triggered Opioid Epidemic, NJ County Says
- Pa. Justices Urged To Deny Appeal Over Risperdal Time-Bar
- A New Weapon To Help FDA Control Enforcement Priorities
- California's Evolving Standard On Expert Opinion Evidence
- Biotech Co. Says Rival Violated Deal With Press Releases
- Patient Says AbbVie's New Trial Needs To Be On All Claims
- Amgen Seeks To Hold Off Generics In FDA Denial Challenge
- Expert Tells NJ Jury He Found Asbestos In J&J Talc
- 4 Cos. Restock IPO Pipeline With Filings Totaling $300M
- Has Rule 36 Peaked At The Federal Circuit?
- 'The Federal Circuit Has Strayed': 2017 In Patent Dissents
- King & Spalding DQ Bid Shouldn't Be Complex, Judge Says
- Pa. Court Won't Junk Risperdal Verdict Against J&J Unit
- FDA Warning Wire: Problems At Pfizer Plant
- High Court Won't Hear Lipitor, Effexor Pay-For-Delay Appeals
- Ex-Katten Muchin Atty Says Jury Misconduct Tainted Trial
- Justices Decline 'Vexatious' Patient's Suit Over CT Scan
- Ky. Says Distributor Failed To Police Opioid Prescriptions
- Emerging Patent Issues In The Cannabis Industry
- Meet The Attys At The Opioid MDL's Negotiating Table
- The Firms That Dominated At The Federal Circuit In 2017
- How The Federal Circuit's Patent Docket Changed In 2017
- Boston Scientific IP Attys Must Defend Doc-Redact Request
- Merck Unit Loses $2.5B Verdict As Hep C Patent Invalidated
- Allergan, Others Cough Up $9M In Product-Hopping Suit
- Insmed Beats Stock-Drop Suit Over Lung Disease Drug
- PTAB Will Review Amgen Patent Tied To Sanofi Eczema Drug
- Pharma Co. Chiasma Can't Escape Investor Suit, Judge Rules
- Momenta, Sandoz Can't Nix Drug Antitrust Suit, Court Told
- Lion Biotech Gets Some Claims Trimmed In Investor Dispute
- Pot Biz Urges Supreme Court To Take Case Against IRS
- Womble Bond Snags 3 Pepper Hamilton Gov't Contracts Attys
- 9th Circ. Won't Revive Investor Suit Over Hep B Drug Trials
- Taxation With Representation: Kirkland, Davis, Skadden, Weil
- Register Your California Cannabis Trademarks Now
- How Emerging Sources Of ESI Will Impact Discovery
- W.Va. Opioid Suit Against McKesson Sent Back To State Court
- Russian Arbitral Award OK'd Against No-Show Pharma Biz
- Bayer Claims Perrigo Infringed Finacea Drug Patents
- ABA Presses For Trade Secrets Safeguards In New NAFTA
- Shunt Patent Reissue Doomed By Recapture Rule: Fed. Circ.
- Bioverativ Shareholders Sue To Block $11.6B Sale To Sanofi
- Put The Brakes On Acceleration Bay Litigation Funder Ruling
- How Natural Experiments Can Help In Estimating Damages
- A Chat With Hogan Lovells HR Chief Allison Friend
- NuVasive Says Rival Hired Key Workers, Copied Spine System
- NY Pharma Sales Rep Cops To $45M Health Fraud Scheme
- Cascadian Investor Says $614M Deal Statement Omitted Info
- Deals Rumor Mill: Healthineers, Blackstone, Takata
- 11th Circ. Affirms 11-Year Stint For $80M Eli Lilly Drug Theft
- Pfizer Says Insurers Owe $30M For Off-Label Marketing Suit
- Ex-NFLer's Pot Decriminalization Suit Hits Possible Snag
- Pfizer Fights In 2nd Circ. Over Interest Claims Deadline
- Illumina Uses Mosaic Of Trial Assets To Score $27M IP Win
- Zimmer Reaches Tentative Settlement In Knee-Implant MDL
- Czech Republic Faces $1B In New Claims From Plasma Co.
- Medical Device, Biotech Cos. Price IPOs Raising $30M Total
- Nektar Inks $1.85B Bristol-Myers Cancer Drug Collaboration
- Considerations For Attorneys Using Artificial Intelligence
- 11th Circ. Asked To Rehear Amgen, Pfizer Win In Enbrel Suit
- Life Science Investor Suits Spiked In '17, Dechert Reports
- PTAB Won't Review 2 Humira Patents In Sandoz Challenge
- Clinical R&D Lab To Scoop Up Pharma Testing Co. For $800M
- 1st Circ. Denies Bid To Stall Solodyn Pay-For-Delay Trial
- Split 9th Circ. Backs EpiCept Win In Patent-Deal Suit
- Teva Exits Philly Reglan Mass Tort With Settlement
- FDA Warning Wire: Bayer's Botched Batches
- Deals Rumor Mill: Walgreens, Actera, Sberbank
- Bristol-Myers Hit With Sanctions Bid Over Abilify Notebooks
- $69M IPO Filed By Biotech That Uses AI To Develop Drugs
- What Hospitals Need To Know Before Forming A Drug Co.
- Agency Accused Of Running MLB Doping, Bribery Scheme
- Medical Device Co. Motus Downsizes IPO Estimate To $21M
- Meningitis Pharmacist Tells Court Restitution Is Too Much
- Eli Lilly Says Cymbalta Users Can't Reopen Axed Case
- Protecting Trade Secrets Disclosed To The FDA
- Will Big Drugmakers Mimic Purdue On Opioid Marketing?
- Expert Ignored Evidence J&J Talc Lacked Asbestos, Jury Told
- Sucampo Investor Seeks Docs For Proposed Mallinckrodt Deal
- Investors In Genocea Herpes-Drug Row Get Lead Counsel
- Vitamin Shoppe Dodges False Ad Suit Over Supplement
- Allergan To Pay $13.5M To End Doctors' Botox Pricing Suit
- Insurer Fights $17.3M In Coverage For Pelvic Mesh Claims
- Pa. Judge Oks J&J Unit's Pelvic Mesh Jurisdiction Appeal
- Bristol-Myers Oversold Lung Cancer Drug, Investors Say
- Shkreli Seeks Light Sentence, Saying His Victims Profited
- Adviser Who Traded On Tip From Atty Gets 6 Months In Prison
- Judging A Book: Duncan Reviews 'Justice And Empathy'
- Health-Focused PE Firm 1315 Capital Closes $300M Fund
- Emerging Trends In FCA Enforcement: 2018 Outlook
- 'Throw' Your Mini-Opening To Get The Best Jury Possible
- ITC Says UK DNA Sequencer Doesn't Violate PacBio Patent
- AbbVie Investor Demands AndroGel Records In Chancery
- 5 Takeaways As White House Dishes On Drug Prices
- Immunomedics, VenBio Settle Del. Proxy Fight Claims
- Biomet Denied Early Wins In Metal Hip Replacements MDL
- Hospital Wants Last Meningitis Case Back In Md.
- Insulet Agrees To Pay $19.5M To End Investor Suit
- Consumers Seek Sanctions For Destroyed Abilify Evidence
- Merck Loses Fed. Circ. Bid To Enforce Nasonex Patent
- Health Hires: Ropes, Brown Rudnick, Mallinckrodt, DLA Piper
- Indivior Sues Teva, Others Over Opioid Addiction Generics
- Gov't Steps Into Eye Products FCA Suit After $3M Settlement
- Wis. Tribe Sues State For Right To Grow Hemp
- Former Aveo Chief Medical Officer Ordered To Pay SEC $50K
- D&O Insurance Coverage For Government Investigations
- ITC Receives Infringement Complaint Over Light Engines
- Cherokee AG Wants Federal Opioid Jurisdiction Case Dropped
- Agency Guidance Limits May Shift Health Care Enforcement
- Fed. Circ. Revives Knee Brace Patent Application
- J&J Hit With Stock-Drop Suit Over Claims Of Asbestos In Talc
- Purdue Says Collegium's Nucynta Sales Infringe 3 Patents
- Biologic Fights Drive PTAB Drug Challenges To Record High
- Deals Rumor Mill: BlackRock, Bayer, Atlantia
- MD's Knowledge Of Risks Bars Hernia Patch Defect Claims
- Sens. Unveil Bill Aimed At Curbing Opioid Crisis
- The Art Of The Litigation Funding Deal
- 11th Circ. Revives Defibrillator Failure Claims Against Zoll
- 5 Cos. Price IPOs Totaling $959M Despite Market Turbulence
- Lewis Brisbois Nabs Baker Donelson IP Pro
- Safe Harbor Protects Protagonist From Infringement Suit
- Cooley Guides Canadian Pot Co.'s $48M Funding Round
- Power, Corruption And Lies: How Juries Are Responding
- FDA Approves Gilead's HIV Med; Rival Claims Infringement
- PTAB Upholds Patent For Medac's Arthritis Drug Injector
- Atty Negotiating Teams Set In Opioid MDL
- FDA's Off-Label Delay Not Enough For Big Drugmakers
- 3rd Circ. Denies GSK Rehearing Bid In Flonase Antitrust Suit
- Senators Urge FDA To Reject Philip Morris Tobacco Device
- AbbVie Filed Patent Suits To Delay Competition, Court Told
- 2017 Patent Litigation: A Year In Review
- Hospital To Face Some Claims In Last Meningitis MDL Case
- Smart Contracts Need Smart Corporate Lawyers
- Pa. Medical Pot Bidder Grilled Over Permit Challenge
- Sanofi Urges Fed. Circ. To Deny Amgen's Redo Bid In IP Row
- Drunk Elephant Trumpets False Skin Benefits, Consumer Says
- Bellicum Hit With Stock Drop Suit In Texas Over Drug Risks
- Witness Preparation Also Requires Witness Training
- Drop In IPRs Tied To Patent Litigation Slowdown
- How Patent Litigation Changed In 2017
- New Normal Takes Shape After TC Heartland Shakeup
- The Firms That Fielded The Most Patent Cases
- Beyond Gilstrap: 5 Judges To Watch In Patent Litigation
- ITC Patent Rebound Shows Signs It's Here To Stay
- After Tragedy, Mom Says Pharmacists Must Seek Docs' Rx OK
- Fed. Circ. Says On-Sale Bar May Invalidate Angiomax Patent
- Gag Order Issued Over Opioid MDL Settlement Talks
- Boehringer, Teva Fight Humana's Bid To Block Aggrenox Deal
- Fed. Circ. Backs USPTO's Term Adjustment For Drug Patent
- FDA Warning Wire: Zimmer Biomet Zapped Again
- Stericycle To Pay Workers $2M To End Wage, Break Claims
- Adocia Adds $200M To Arbitration Demand Against Eli Lilly
- 4th Circ. Upholds $18.5M Boston Scientific Mesh Verdict
- How To Fix Your Broken Client Teams
- Valeant Seeks To Move NY Investor Fraud Suit To NJ
- Alabama Sues Purdue Pharma Over Role In Opioid Crisis
- Omnicare Settlement: Outlier Or Beginning Of Broader Trend?
- Preemption In Pharmaceutical Cases: 2017 In Review
- Surgery Center, Estate Contest Punitives In Meningitis MDL
- Ex-Doc Gets 8 Years For Fraud, Illegally Dispensing Opioids
- Bayer Offers Commitments To EU For $63.5B Monsanto Buy
- Cornell University Can't Restart Settled Patent Fight
- Ex-Aveo Exec Fights SEC Penalty, Says He's Learned Lesson
- Fed. Circ. Backs Toss Of AbbVie's Humira License Suit
- Deals Rumor Mill: Pfizer, ADM, Bhushan Steel
- US Teva Worker Can Sue Co.'s Israeli Branch, Judge Says
- Vertex To Pay $4.75M To End TCPA Case Over Hep C Faxes
- Atty Scolded For '#Killinnazis' Exits Pa. Xarelto Cases
- IRS Asks Supreme Court To Skip Appeal In Marijuana Case
- Filter MDL Puts FDA Clearance Evidence Back On The Table
- Amgen's Suit To Shield Cancer Treatment Biosimilar Tossed
- Biomed Co. Appealed Too Late In Trade Secrets Row: 7th Circ.
- 10 Firms To Steer IPOs Exceeding $1.8B To Start February
- $47M Pulled From Biotech Wasn't Returned, Del. Court Told
- 2nd Circ. Affirms Dismissal Of Dr. Scholl's Class Action
- Georgia Man Gets 5 Years For $20M Investment Scheme
- Mylan Says Celgene Claims Still Timely In Antitrust Suit
- Philly DA Accuses Drugmakers Of Deceptive Opioid Marketing
- 9th Circ. Botched Escobar Standard, High Court Hears
- Buchalter Adds 3 IP Pros From Greenberg Traurig
- Deals Rumor Mill: Boeing, Alibaba, Nestle
- Aveo Agrees To $18M Deal To End Cancer Drug Investor Suit
- Ex-Biotech CFO Avoids Prison For Hornswoggling Auditor
- How To Serve Your Blind Client Effectively
- 1 Firm Leads January IPO Activity As 2018 Starts Bullish
- NY AG Sues Insys Over 'Perilous' Opioid Marketing
- Insurers Sue Pfizer To Avoid Covering $400M Settlement
- Inside The Opioid MDL's Big Closed-Door Hearing
- Life Sciences Group Of The Year: Sullivan & Cromwell
- Intercept Drug Gets Black-Box Warning After Dosing Deaths
- 5th Circ. Won't Interfere With Opioid Probe Into Texas Doc
- DuPont Whistleblower Didn't Exhaust Options, 3rd. Circ. Says
- Allergan To Pay Teva $700M To End Working-Capital Dispute
- Evolving Due Process In The Digital Age
- DOJ Has New Policy On FCA Dismissals — Finally